Skip to main content
Medical information Clinical review pending

Endocrine Testing

Cpeptide Post Prandial Serum Test

The Cpeptide Post Prandial Serum Test measures C-peptide levels after a meal to assess your body's insulin production. This test helps manage diabetes by evaluating pancreatic function.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Serum (minimum 0.5 mL) collected in an SST tube.
Results
Confirm with the laboratory before booking.
Preparation
Fasting is not required. The sample must be collected 2 hours after starting a standard meal.
Test priceKSh 2,457

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Cpeptide Post Prandial Serum Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Monitoring insulin production in diagnosed diabetes
  • ✓Evaluating symptoms suggestive of insulin deficiency or resistance
  • ✓Guiding diabetes treatment adjustments
  • ✓Differentiating between types of diabetes
  • ✓Assessing pancreatic beta-cell function
02

In plain language

What this test helps you understand

Assesses endogenous insulin production in response to a meal, aiding in the diagnosis and management of diabetes mellitus, particularly distinguishing between type 1 and type 2 diabetes, and evaluating pancreatic beta-cell function.
The Cpeptide Post Prandial Serum Test is a diagnostic tool used to assess the body’s insulin production in response to food intake. This test is particularly important for individuals with diabetes, as it helps healthcare providers understand how well the pancreas is functioning and how effectively it is producing insulin after meals. Understanding insulin levels is crucial for managing diabetes and preventing complications.

This test measures the level of C-peptide in the blood, which is a byproduct of insulin production. After consuming a meal, the pancreas releases insulin to help regulate blood sugar levels, and C-peptide levels rise accordingly. By analyzing these levels, healthcare professionals can gain insights into the patient’s insulin production capabilities.

Results from the Cpeptide Post Prandial Serum Test can vary based on individual health conditions. Generally, higher levels of C-peptide indicate better insulin production, while lower levels may suggest insulin deficiency. It’s essential to discuss your results with your healthcare provider for proper interpretation and guidance.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationFasting is not required. The sample must be collected 2 hours after starting a standard meal.
SampleSerum (minimum 0.5 mL) collected in an SST tube.
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Results can be affected by certain medications and other medical conditions. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

C-peptide is a substance released alongside insulin by the pancreas. Measuring it helps assess how much insulin your body is producing.
This test is done post-meal (prandial) because eating stimulates the pancreas to release insulin. Measuring C-peptide then shows how well your pancreas responds to food.
You do not need to fast. The blood sample needs to be taken exactly 2 hours after you start eating a meal.
Higher C-peptide levels generally indicate good insulin production, while lower levels might suggest the pancreas isn't producing enough insulin. Your doctor will interpret the results in the context of your overall health.
While it can help differentiate types of diabetes, it's usually used alongside other tests for diagnosis and primarily for managing existing diabetes.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp